A detailed history of Allianz Asset Management Gmb H transactions in Veracyte, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 6,700 shares of VCYT stock, worth $293,527. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,700
Holding current value
$293,527
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$21.0 - $35.25 $140,700 - $236,175
6,700 New
6,700 $228,000
Q2 2021

Aug 16, 2021

SELL
$32.94 - $56.62 $2.05 Million - $3.52 Million
-62,233 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$44.47 - $81.38 $2.21 Million - $4.05 Million
-49,801 Reduced 44.45%
62,233 $3.35 Million
Q4 2020

Feb 16, 2021

BUY
$32.49 - $61.88 $642,359 - $1.22 Million
19,771 Added 21.43%
112,034 $5.48 Million
Q3 2020

Nov 13, 2020

SELL
$26.73 - $35.67 $6.96 Million - $9.29 Million
-260,438 Reduced 73.84%
92,263 $3 Million
Q2 2020

Aug 14, 2020

SELL
$19.49 - $28.11 $3.06 Million - $4.41 Million
-156,837 Reduced 30.78%
352,701 $9.13 Million
Q1 2020

May 14, 2020

BUY
$16.13 - $30.17 $29,130 - $54,487
1,806 Added 0.36%
509,538 $12.4 Million
Q4 2019

Feb 13, 2020

BUY
$20.78 - $29.99 $672,461 - $970,506
32,361 Added 6.81%
507,732 $14.2 Million
Q3 2019

Nov 13, 2019

SELL
$23.87 - $30.93 $534,019 - $691,965
-22,372 Reduced 4.49%
475,371 $11.4 Million
Q2 2019

Aug 08, 2019

SELL
$22.1 - $28.56 $1.82 Million - $2.35 Million
-82,192 Reduced 14.17%
497,743 $14.2 Million
Q1 2019

May 13, 2019

SELL
$12.0 - $25.76 $771,876 - $1.66 Million
-64,323 Reduced 9.98%
579,935 $14.5 Million
Q4 2018

Feb 14, 2019

BUY
$9.15 - $14.85 $58,669 - $95,218
6,412 Added 1.01%
644,258 $8.11 Million
Q3 2018

Nov 13, 2018

BUY
$9.55 - $12.64 $4.27 Million - $5.65 Million
446,817 Added 233.9%
637,846 $6.09 Million
Q2 2018

Aug 13, 2018

BUY
$5.39 - $9.66 $1.03 Million - $1.85 Million
191,029 New
191,029 $1.78 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.14B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.